T1	CHEM 9 36	ácido épsilon aminocaproico
#1	AnnotatorNotes T1	C0000608; 6-aminocaproic acid; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T2	PROC 81 105	estudio no observacional
T3	PROC 115 182	ensayo clínico terapéutico, comparativo, prospectivo y aleatorizado
#2	AnnotatorNotes T3	C1579762; comparative study research; Research Activity + C0033522; Prospective Studies; Research Activity + C0206034; Clinical Trials, Randomized; Research Activity
T4	CHEM 322 326	AEAC
#3	AnnotatorNotes T4	C0000608; 6-aminocaproic acid; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T5	PROC 269 288	evaluar la eficacia
#4	AnnotatorNotes T5	C1707887; Efficacy Study; Research Activity
T6	CHEM 293 320	ácido épsilon aminocaproico
#5	AnnotatorNotes T6	C0000608; 6-aminocaproic acid; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T7	DISO 359 371	sangramiento
#6	AnnotatorNotes T7	C0019080; Hemorrhage; Pathologic Function
T8	PROC 392 415	transfusiones homólogas
T9	ANAT 521 527	sangre
#7	AnnotatorNotes T9	C0005767; Blood; Body Substance
T10	ANAT 716 724	glóbulos
#8	AnnotatorNotes T10	C0005773; Blood Cells; Cell
T11	PROC 685 697	intervención
#9	AnnotatorNotes T11	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T12	PROC 966 986	transfusión homóloga
T13	PROC 40 56	cirugía torácica
#10	AnnotatorNotes T13	C0524832; Thoracic Surgical Procedures; Therapeutic or Preventive Procedure
T14	PROC 223 239	cirugía torácica
#11	AnnotatorNotes T14	C0524832; Thoracic Surgical Procedures; Therapeutic or Preventive Procedure
T15	DISO 465 487	reacciones indeseables
#12	AnnotatorNotes T15	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T16	CHEM 611 615	AEAC
#13	AnnotatorNotes T16	C0000608; 6-aminocaproic acid; Amino Acid, Peptide, or Protein · Pharmacologic Substance
T17	PROC 725 738	transfundidas
#14	AnnotatorNotes T17	C1879316; Transfusion (procedure); Therapeutic or Preventive Procedure
T18	DISO 1065 1087	reacciones indeseables
#15	AnnotatorNotes T18	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T19	PROC 599 606	tratado
#16	AnnotatorNotes T19	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T20	ANAT 816 824	glóbulos
#17	AnnotatorNotes T20	C0005773; Blood Cells; Cell
T22	LIVB 188 197	pacientes
#18	AnnotatorNotes T22	C0030705; Patients; Patient or Disabled Group
T23	Time 372 385	posoperatorio
#19	AnnotatorNotes T23	C0032790; Postoperative Period; Temporal Concept
T24	Spec_cue 456 464	posibles
T25	Time 544 557	posoperatorio
#20	AnnotatorNotes T25	C0032790; Postoperative Period; Temporal Concept
T26	Duration 642 647	las 6
T27	Duration 655 667	las 24 horas
T28	Time 745 760	transoperatorio
#21	AnnotatorNotes T28	C0021891; Intraoperative Period; Temporal Concept | C0456904; Intraoperative; Temporal Concept
T29	Time 845 858	posoperatorio
#22	AnnotatorNotes T29	C0032790; Postoperative Period; Temporal Concept
T30	LIVB 943 952	pacientes
#23	AnnotatorNotes T30	C0030705; Patients; Patient or Disabled Group
T21	Duration 419 431	este período
T32	LIVB 898 911	grupo estudio
#24	AnnotatorNotes T32	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
T31	LIVB 626 633	control
#25	AnnotatorNotes T31	C0009932; Control Groups; Group
A1	Assertion T15 Speculated
T33	Quantifier_or_Qualifier 92 105	observacional
A2	Assertion T33 Negated
R1	Has_Quantifier_or_Qualifier Arg1:T2 Arg2:T33	
T34	Neg_cue 89 91	no
R2	Negation Arg1:T34 Arg2:T33	
T35	Neg_cue 1003 1005	No
T36	CONC 1018 1029	diferencias
A3	Assertion T36 Negated
#26	AnnotatorNotes T36	C1705241; Delta (difference); Quantitative Concept
R3	Negation Arg1:T35 Arg2:T36	
R4	Used_for Arg1:T1 Arg2:T13	
T37	Quantifier_or_Qualifier 57 65	electiva
#27	AnnotatorNotes T37	C0439608; elective; Temporal Concept
R5	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T37	
R6	Experiences Arg1:T22 Arg2:T14	
T38	Quantifier_or_Qualifier 240 248	electiva
#28	AnnotatorNotes T38	C0439608; elective; Temporal Concept
R7	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T38	
R8	Used_for Arg1:T6 Arg2:T14	
R9	Used_for Arg1:T4 Arg2:T14	
R10	Overlap Arg1:T7 Arg2:T23	
R11	Overlap Arg1:T8 Arg2:T21	
R12	Overlap Arg1:T7 Arg2:T21	
R13	Speculation Arg1:T24 Arg2:T15	
R14	Before Arg1:T4 Arg2:T15	
R15	Before Arg1:T6 Arg2:T15	
R20	Overlap Arg1:T15 Arg2:T21	
R21	Experiences Arg1:T22 Arg2:T7	
R22	Experiences Arg1:T22 Arg2:T6	
R23	Experiences Arg1:T22 Arg2:T4	
R24	Experiences Arg1:T22 Arg2:T8	
R25	Experiences Arg1:T22 Arg2:T15	
T40	CONC 509 537	cantidad de sangre colectada
R26	Overlap Arg1:T40 Arg2:T25	
R27	Used_for Arg1:T16 Arg2:T19	
R28	Overlap Arg1:T40 Arg2:T26	
R29	Overlap Arg1:T40 Arg2:T27	
R33	Overlap Arg1:T17 Arg2:T28	
T41	CONC 704 738	unidades de glóbulos transfundidas
T42	CONC 804 824	cantidad de glóbulos
R34	Overlap Arg1:T42 Arg2:T29	
R35	Experiences Arg1:T32 Arg2:T17	
R36	Experiences Arg1:T30 Arg2:T12	
R37	Experiences Arg1:T32 Arg2:T12	
R38	Experiences Arg1:T30 Arg2:T17	
R39	Overlap Arg1:T19 Arg2:T11	
R18	Experiences Arg1:T31 Arg2:T11	
R16	Before Arg1:T11 Arg2:T40	
#29	AnnotatorNotes T33	C3658316; Observational Studies as Topic; Intellectual Product (?)
A4	Experiencer T22 Patient
A5	Experiencer T31 Patient
A6	Experiencer T32 Patient
A7	Experiencer T30 Patient
